Skip to main content
  • Management
      |Management
    • Compensation
    • Economics
    • Leadership
    • Legal News
    • Mergers & Acquisitions
    • Patient Care
    • Policy & Regulations
    • Practice Management
    • Professional Associations
    • Quality
    • Staffing
  • Imaging
      |Imaging
    • CT
    • MRI
    • Nuclear Medicine
    • Ultrasound
    • Women's Imaging
    • X-ray
  • Technology
      |Technology
    • Artificial Intelligence
    • Enterprise Imaging
    • Imaging Informatics
    • Informatics
    • PACS
  • Videos
  • Conferences
      |Conferences
    • ACR
    • AHRA
    • ARRS
    • ASRT
    • RBMA
    • RSNA
    • SBI
    • SCCT
    • SIIM
    • SIR
    • SNMMI
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025
    • Class of 2024

Search form

Home

News You Need to Know Today
Theranostic as effective as Pluvicto goes to clinical trial | MRI not suitable for all ICH cases | US mobile stroke unit rollout
Friday, May 30, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Prostate cancer theranostic, said to match effectiveness of Pluvicto, heads to clinical trial

ART-101 is a prostate-specific membrane antigen-targeting small molecule that can pair with multiple isotopes, including actinium-225, lutetium-177 and terbium-161. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Prostate cancer theranostic, said to match effectiveness of Pluvicto, heads to clinical trial

Share on Twitter Share on Facebook Share on Linkedin
ART-101 is a prostate-specific membrane antigen-targeting small molecule that can pair with multiple isotopes, including actinium-225, lutetium-177 and terbium-161. 
READ MORE >

Study challenges use of MRI in spontaneous deep intracerebral hemorrhage

Spontaneous ICH carries a heightened risk of mortality, making locating its origin in a timely manner critical to outcomes.

READ MORE >
MRI may not be suitable for spontaneous deep ICH
Share on Twitter Share on Facebook Share on Linkedin

Study challenges use of MRI in spontaneous deep intracerebral hemorrhage

Share on Twitter Share on Facebook Share on Linkedin
MRI may not be suitable for spontaneous deep ICH
Spontaneous ICH carries a heightened risk of mortality, making locating its origin in a timely manner critical to outcomes.
READ MORE >

American Lung Association expresses 'concern' over recent CT-related cancer study

The organization is worried  the paper's estimates will cause patients to “forgo necessary, lifesaving medical imaging."

READ MORE >
lung cancer screening
Share on Twitter Share on Facebook Share on Linkedin

American Lung Association expresses 'concern' over recent CT-related cancer study

Share on Twitter Share on Facebook Share on Linkedin
lung cancer screening
The organization is worried  the paper's estimates will cause patients to “forgo necessary, lifesaving medical imaging."
READ MORE >

Siemens Healthineers deploys its first mobile stroke unit in the US

The new device marks a “significant step forward” in American stroke care, the company contends. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Siemens Healthineers deploys its first mobile stroke unit in the US

Share on Twitter Share on Facebook Share on Linkedin
The new device marks a “significant step forward” in American stroke care, the company contends. 
READ MORE >

New findings support dynamic CT use in treatment-resistant postpartum hemorrhage

CT for severe PPH cases could help identify the source of bleeding with greater accuracy, leading to improved management and outcomes. 

READ MORE >
CT identifies postpartum hemorrhage resistant to treatment
Share on Twitter Share on Facebook Share on Linkedin

New findings support dynamic CT use in treatment-resistant postpartum hemorrhage

Share on Twitter Share on Facebook Share on Linkedin
CT identifies postpartum hemorrhage resistant to treatment
CT for severe PPH cases could help identify the source of bleeding with greater accuracy, leading to improved management and outcomes. 
READ MORE >

In Other News

Research brief: Cybersecurity threats inherent to AI-aided remote patient monitoring

Leveraging the upsides of RPM with AI demands human attention to numerous challenges. Primary among these are privacy and cybersecurity risks, researchers report. 

READ MORE >
remote patient monitoring with AI
Share on Twitter Share on Facebook Share on Linkedin

Research brief: Cybersecurity threats inherent to AI-aided remote patient monitoring

Share on Twitter Share on Facebook Share on Linkedin
remote patient monitoring with AI
Leveraging the upsides of RPM with AI demands human attention to numerous challenges. Primary among these are privacy and cybersecurity risks, researchers report. 
READ MORE >

Breast, lung imaging facilities often in close proximity, with opportunity for same-visit screenings

Over 38% of mammography facilities are within 1 mile of a nearby LCS provider, and 60% of this segment share the same address. 

READ MORE >
breast cancer mammography screening mammogram scheduling
Share on Twitter Share on Facebook Share on Linkedin

Breast, lung imaging facilities often in close proximity, with opportunity for same-visit screenings

Share on Twitter Share on Facebook Share on Linkedin
breast cancer mammography screening mammogram scheduling
Over 38% of mammography facilities are within 1 mile of a nearby LCS provider, and 60% of this segment share the same address. 
READ MORE >

Private equity's influence continues to rise in cardiology—what does that mean for patient care?

Rishi Wadhera, MD, MPP, MPhil, a cardiologist who also specializes in healthcare policy, spoke to Cardiovascular Business about the good, the bad and the unknown when it comes to private equity's role in cardiology.

READ MORE >
Rishi Wadhera, MD, MPP, MPhil, associate director of the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, and an associate professor of health policy and management, Harvard School of Public Health, explains the impact of private equity ownership of hospitals and private practices.
Share on Twitter Share on Facebook Share on Linkedin

Private equity's influence continues to rise in cardiology—what does that mean for patient care?

Share on Twitter Share on Facebook Share on Linkedin
Rishi Wadhera, MD, MPP, MPhil, associate director of the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, and an associate professor of health policy and management, Harvard School of Public Health, explains the impact of private equity ownership of hospitals and private practices.
Rishi Wadhera, MD, MPP, MPhil, a cardiologist who also specializes in healthcare policy, spoke to Cardiovascular Business about the good, the bad and the unknown when it comes to private equity's role in cardiology.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Ketamine safe for IR procedures | Reintervention rates after PAE | IRs see notable pay gain | Stroke-related costs on the rise
EM docs quash thousands of CT scan requests | Societies push Congress to help radiology | CT links bone density and brain aging
Concerns over CMS cuts to imaging spending | FDA to stop mailing MQSA materials | ACR opposes radiation safety rule change
Telix and ITM join forces in $1.6B radiopharma merger | More rads concentrating practice on IR | AI reduces GBCA reliance | More
The economic impact of the contrast shortage | New data on smoking and aortic calcification | AI reduces repeat GBCA exposures
FDA clears brain cancer imaging agent | GE mulls $1B radiopharma purchase | ACR concerned with proposed CMS imaging cuts | More
Medicare spending for RT on the decline | AMA's 2027 CPT radiology codes | CMS devaluing radiology | OOP charges for patients
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup